Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006
Door to Thrombolysis: ER Reorganization and Reduced Delays to Acute Stroke Treatment
Neurol 67:334-336, Lindsberg,P.J.,et al, 2006
Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Pro
Stroke 37:2436-2437,2440, Schellinger,P.D. &Hacke,W., 2006
Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Con
Stroke 37:2438-2439,2440, Ford,G.A., 2006
Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
Stroke 37:1822-1827, Audebert,H.,et al, 2006
Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke: Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
AJNR 27:1177-1182, W.S. Smith, for the Multi MERCI Investigators, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006
Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke
Stroke 37:2168-2169, Wiese,K.M.,et al, 2006
Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006
Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006
Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Therapy of Basilar Artery Occlusion, A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Stroke 37:922-928, Lindsberg,P.J.&Mattle,H.P., 2006
Thrombolytic Therapy of Acute Ischemic Stroke During Pregnancy
Neurol 66:768-770, Murugappan,A.,et al, 2006
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005
Effect of Stress Related to the 9/11/2001 Terror Attack on Seizures in Patients with Epilepsy
Neurol 64:1815-1816, Klein,P. &van Passel,L., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005
IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005
Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005
Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005
Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005
Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005
Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005
Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005
Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005
Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005
Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005
NT-3 Promotes Nerve Regeneration and Sensory Improvement in CMT1A Mouse Models and in Patients
Neurol 65:681-689, 662, Sahenk,Z.,et al, 2005
Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005
Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005
REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005
Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005
Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005